Northerner
Admin (Retired)
- Relationship to Diabetes
- Type 1
A first-of-its-kind study by researchers at the Keck School of Medicine of the University of Southern California (USC) indicates that healthy, obese, reproductive-age women who use long-acting reversible contraception (LARC) containing the hormone progestin have a slightly increased risk for developing type 2 diabetes when compared to those who use non-hormonal contraception.
The research concludes that progestin-releasing LARC appears to be safe for use by such women but needs further investigation.
http://www.sciencedaily.com/releases/2013/02/130207172115.htm
The research concludes that progestin-releasing LARC appears to be safe for use by such women but needs further investigation.
http://www.sciencedaily.com/releases/2013/02/130207172115.htm